![6-[3-(1-adamantyl)-4-methoxy-phenyl]naphthalene-2-carboxylic Acid CAS 106685-40-9](/images/load_icon.gif){kind=icon}
![6-[3-(1-adamantyl)-4-methoxy-phenyl]naphthalene-2-carboxylic Acid CAS 106685-40-9](/photo/pl169971783-6_3_1_adamantyl_4_methoxy_phenyl_naphthalene_2_carboxylic_acid_cas_106685_40_9.jpg)
製品詳細
起源の場所: 中国
ブランド名: Sunshine
証明: ISO,COA
モデル番号: 106685-40-9
支払いと送料の条件
最小注文数量: 交渉
価格: 交渉可能
パッケージの詳細: アルミ製の紙袋,ドラム
受渡し時間: 7〜15日
支払条件: T/T,L/C,D/A,ウェスタンユニオン
供給の能力: トン
CAS番号:: |
106685-40-9 |
外見:: |
白色から薄白色粉末 |
分子式:: |
C28H28O3 |
分子重量:: |
412.52 |
EINECS番号:: |
620-513-9 |
MDL NO:: |
MFCD03106112 |
CAS番号:: |
106685-40-9 |
外見:: |
白色から薄白色粉末 |
分子式:: |
C28H28O3 |
分子重量:: |
412.52 |
EINECS番号:: |
620-513-9 |
MDL NO:: |
MFCD03106112 |
Product Description:
Product Name: 6-[3-(1-adamantyl)-4-metho xy-phenyl]naphthalene-2-carboxylic acid CAS NO: 106685-40-9
Synonyms:
Adapalene;
Adapalenum;
Differin;
6-[3-(1-Adamantyl)-4-methoxyphe nyl]-2-naphthoic Acid;
6-(3-(Adamantan-1-yl)-4-methoxyphe nyl)-2-naphthoic acid;
2-Naphthalenecarboxylic acid, 6-(4-metho xy-3-tricyclo[3.3.1.1]dec-1-ylphenyl)-;
6-[3-(Adamantan-1-yl)-4-methoxyphe nyl]-2-naphthoic acid;
Adapaleno;
Adaferin;
Chemical & Physical Properties:
Appearance : white to off-white powder
Assay :≥99.0%
Solubility: DMSO: >10mg/mL
Density:1.233 g/cm3
Boiling Point:606.3℃ at 760 mmHg
Melting Point: 319-322℃
Flash Point:205.9℃
Refractive Index:1.654
Vapor Pressure:1.49E-15mmHg at 25°C
Adapalene(CD-271; Differin), a synthetic retinoid, is a retinoic acid receptor agonist (RAR).Target: Retinoic acid receptor agonist (RAR)Adapalene is a third-generation topical retinoid primarily used in the treatment of mild-moderate acne and is also used (off-label) to treat keratosis pilaris as well as other skin conditions. Adapalene is possibly more effective than tretinoin 0.025% gel in the treatment of acne vulgaris.
Thirty-six rats of either sex were divided into six groups (two control groups, and an etodolac, indomethacin, tretinoin and adapalene group) of six animals each. Each group was given different drugs or chemicals. The inhibitory activities of the drugs were determined on carrageenan-induced rat-paw oedema. The inhibition rate (53.48%) in the tretinoin group was found to be higher thanadapalene and controls (P < 0.05). Adapalene was found to have an inhibition rate of 10.28%, and when compared with the other groups, was found to have no statistically significant anti-inflammatory activit.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.
Tags:
